These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 9698932
1. A comparison of the inhibitory activity of selective PDE4 inhibitors on eosinophil recruitment in guinea pig skin. Teixeira MM, Miotla JM, Cooper N, Gristwood RW, Hellewell PG. Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():193-6. PubMed ID: 9698932 [Abstract] [Full Text] [Related]
6. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4. Blease K, Burke-Gaffney A, Hellewell PG. Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364 [Abstract] [Full Text] [Related]
9. Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase. Souness JE, Scott LC. Biochem J; 1993 Apr 15; 291 ( Pt 2)(Pt 2):389-95. PubMed ID: 8387267 [Abstract] [Full Text] [Related]
10. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Tenor H, Hatzelmann A, Church MK, Schudt C, Shute JK. Br J Pharmacol; 1996 Aug 15; 118(7):1727-35. PubMed ID: 8842438 [Abstract] [Full Text] [Related]
11. Aryl sulfonamides as selective PDE4 inhibitors. Montana JG, Buckley GM, Cooper N, Dyke HJ, Gowers L, Gregory JP, Hellewell PG, Kendall HJ, Lowe C, Maxey R, Miotla J, Naylor RJ, Runcie KA, Tuladhar B, Warneck JB. Bioorg Med Chem Lett; 1998 Oct 06; 8(19):2635-40. PubMed ID: 9873594 [Abstract] [Full Text] [Related]
13. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633. Cohan VL, Showell HJ, Fisher DA, Pazoles CJ, Watson JW, Turner CR, Cheng JB. J Pharmacol Exp Ther; 1996 Sep 06; 278(3):1356-61. PubMed ID: 8819523 [Abstract] [Full Text] [Related]
14. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4. Hughes B, Howat D, Lisle H, Holbrook M, James T, Gozzard N, Blease K, Hughes P, Kingaby R, Warrellow G, Alexander R, Head J, Boyd E, Eaton M, Perry M, Wales M, Smith B, Owens R, Catterall C, Lumb S, Russell A, Allen R, Merriman M, Bloxham D, Higgs G. Br J Pharmacol; 1996 Jul 06; 118(5):1183-91. PubMed ID: 8818342 [Abstract] [Full Text] [Related]
17. Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation. Teixeira MM, Rossi AG, Giembycz MA, Hellewell PG. Br J Pharmacol; 1996 Aug 06; 118(8):2099-106. PubMed ID: 8864548 [Abstract] [Full Text] [Related]
18. Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4. Kleinman EF, Campbell E, Giordano LA, Cohan VL, Jenkinson TH, Cheng JB, Shirley JT, Pettipher ER, Salter ED, Hibbs TA, DiCapua FM, Bordner J. J Med Chem; 1998 Jan 29; 41(3):266-70. PubMed ID: 9464356 [No Abstract] [Full Text] [Related]
19. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors. Kelly JJ, Barnes PJ, Giembycz MA. Br J Pharmacol; 1998 May 29; 124(1):129-40. PubMed ID: 9630352 [Abstract] [Full Text] [Related]